Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a revenue of 702 million yuan for H1 2025, representing a year-on-year increase of 51.39%. The net profit attributable to the parent company was -18 million yuan, an increase of 73.01% year-on-year. The gross margin was 54.31%, up by 8.1 percentage points [2][4]. - In Q2 2025, the company achieved a revenue of 408 million yuan, a year-on-year increase of 78.73%, with a net profit of -3 million yuan, reflecting a 96.68% year-on-year increase. The gross margin for this quarter was 51.59%, an increase of 13.7 percentage points [2][4]. - The company's revenue from testing equipment and measurement equipment reached 426 million yuan and 256 million yuan respectively in H1 2025, with year-on-year increases of 38.9% and 70.5%. The gross margins for these segments were 62.2% and 41.3%, increasing by 11.6 percentage points and 4.7 percentage points respectively [9]. - R&D investment for H1 2025 was 285 million yuan, a year-on-year increase of 37.79%, with a total of 577 R&D personnel, of which 56% held master's degrees or higher [9]. - The company has a robust order backlog and is seeing growth in advanced process products, particularly in the HBM and emerging advanced packaging sectors [9]. Summary by Sections Financial Performance - H1 2025 revenue: 702 million yuan, up 51.39% YoY - H1 2025 net profit: -18 million yuan, up 73.01% YoY - H1 2025 gross margin: 54.31%, up 8.1 percentage points [2][4]. Product and Market Development - Major products include various wafer defect detection and measurement devices, with significant new deliveries in the first half of 2025 [9]. - The company is benefiting from domestic substitution and increased demand for advanced process measurement equipment due to U.S. export controls [9]. Future Outlook - Expected net profits for 2025-2027 are projected at 155 million yuan, 390 million yuan, and 662 million yuan respectively, with corresponding PE ratios of 187x, 74x, and 44x [9].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 100.30 [6][7]. Core Insights - The company achieved a revenue of RMB 702 million in 1H25, representing a year-on-year increase of 51.39%, with a narrowing net loss of RMB 18.35 million [1][2]. - The second quarter of 2025 saw revenue of RMB 408 million, up 78.73% year-on-year and 38.71% quarter-on-quarter, with a net loss of RMB 339,390 [2][3]. - The gross margin improved by 8.08 percentage points to 54.31% in 1H25, driven by continuous shipments of defect detection equipment and growing orders for advanced packaging equipment [1][2]. Summary by Sections Financial Performance - In 1H25, the company reported a revenue of RMB 702 million, with a gross margin of 54.31% and a net loss of RMB 18.35 million, which is a reduction compared to previous periods [1][2]. - The revenue from detection equipment was RMB 426 million, up 38.9% year-on-year, while measurement equipment revenue reached RMB 256 million, growing by 70.5% [2]. Product Development - The company has successfully developed and delivered over 300 units of non-pattern wafer defect detection equipment and over 400 units of patterned wafer defect detection equipment [3]. - The company’s advanced packaging equipment, including 3D AOI and three-dimensional morphology measurement devices, has seen continuous growth in orders since validation by leading domestic clients [3][4]. Market Outlook - The company is actively validating its dark field nano-pattern wafer detection equipment with major domestic clients, receiving positive feedback and driving order growth [4]. - The report anticipates strong demand across various semiconductor sectors, including logic, storage, and power semiconductors, supporting the company's growth trajectory [4]. Earnings Forecast and Valuation - The revenue forecasts for 2025, 2026, and 2027 are RMB 2.07 billion, RMB 3.20 billion, and RMB 4.67 billion, respectively, with corresponding net profits of RMB 208.92 million, RMB 514.62 million, and RMB 794.23 million [5][10]. - The report assigns a price-to-sales (PS) ratio of 15.5 for 2025, reflecting the company's high growth potential in a low domestic market penetration environment [5].

Investment Rating - The investment rating for the company is "Buy-A" with a target price of 103.02 CNY per share, maintaining the rating [6]. Core Viewpoints - The company has achieved significant revenue growth driven by technological breakthroughs and accelerated domestic substitution demand, leading to an expansion of its customer base and order volume. Although the company has not yet turned a profit, the loss margin has narrowed significantly year-on-year [2][9]. - The company has increased its R&D investment and implemented equity incentives, which have led to higher share-based payment expenses, putting some pressure on short-term profits. The overall gross margin for H1 2025 was 54.31%, an increase of 8.08 percentage points year-on-year [2][9]. - The company has successfully mass-produced seven major devices and has established a complete yield management solution with nine series of equipment and three series of software, meeting the needs of leading domestic customers [3][4]. Financial Performance Summary - In H1 2025, the company achieved operating revenue of 702 million CNY, a year-on-year increase of 51.39%. The net profit attributable to the parent company was a loss of 18 million CNY, a year-on-year reduction in loss of 73.01% [1][2]. - For Q2 2025, the company reported operating revenue of 408 million CNY, a year-on-year increase of 78.73%, with a net profit loss of 3 million CNY, a year-on-year reduction in loss of 96.68% [1][2]. - The company expects revenues of 2.071 billion CNY, 3.023 billion CNY, and 4.202 billion CNY for the years 2025, 2026, and 2027, respectively, with net profits of 249 million CNY, 453 million CNY, and 636 million CNY for the same years [9][11].

Core Viewpoint - Shenzhen Zhongke Feimece Technology Co., Ltd. reported a significant increase in revenue for the first half of 2025, driven by advancements in core technology and a growing customer base in the semiconductor quality control sector [3][4][5]. Company Overview and Financial Indicators - The company achieved operating revenue of approximately 702.17 million yuan, representing a year-on-year increase of 51.39% [4]. - The net profit attributable to shareholders was -18.35 million yuan, showing a reduction in losses compared to the previous year [4][5]. - The company's net assets increased by 3.54% to approximately 2.52 billion yuan [4]. Industry Situation - The semiconductor equipment industry is closely tied to the semiconductor industry's overall health, with a projected global wafer capacity growth of 6% in 2024 and 7% in 2025 [5][6]. - China is expected to see a 15% increase in wafer capacity in 2024, further growing by 14% in 2025, making it the largest producer and consumer of integrated circuits globally [5][6]. - The semiconductor testing and measurement equipment market is projected to reach 14.35 billion USD in 2024, with a compound annual growth rate of 27.73% from 2020 to 2024 in China [5][6]. Main Business Situation - The company focuses on high-end semiconductor quality control, providing a full range of yield management solutions, including equipment products, intelligent software, and related services [7][8]. - The product lineup includes various optical detection and measurement devices, with significant advancements in technology and product offerings [7][8][9]. - The company has established a comprehensive strategy in equipment and software, enhancing its competitive edge in the semiconductor market [7][8]. Product Development - The company has delivered over 300 units of non-pattern wafer defect detection equipment, with a growing market share among major integrated circuit manufacturers [10][11]. - The pattern wafer defect detection equipment has also seen increased adoption, with over 400 units delivered to various customers [11][12]. - The three-dimensional morphology measurement equipment has been successfully integrated into production lines, with over 200 units delivered [12].

Macro Analysis - The current market is influenced by three main macro variables: domestic demand recovery, policy implementation effects, and external environment changes[9] - The easing of US-China tariff negotiations helps alleviate market risk appetite pressures, but the long-term relationship remains competitive[9] - The economy is undergoing an L-shaped recovery, with manageable short-term pressures on foreign trade and employment, while low inflation remains a core challenge[9] Investment Recommendations - Strategic focus on Hong Kong stocks is advised, as de-dollarization benefits liquidity-sensitive markets[10] - A-shares are expected to experience high volatility, emphasizing the need to capture structural opportunities[10] - Suggested asset allocation includes resilient dividend assets in finance, resource sectors, and public utilities, with technology remaining a key focus[10] Company Highlights - Excellence New Energy (688196.SH) is a leader in biodiesel production, with a capacity of approximately 500,000 tons and a focus on raw material substitution[12] - Yipuli (002096.SZ) achieved revenue of 8.546 billion yuan in 2024, a 1.4% increase, with net profit rising by 12.49% to 713 million yuan[17] - Zijin Mining (601899.SH) expects copper production to reach 1.15 million tons in 2025, with gold production projected at 85 tons[24] Risk Factors - Potential risks include policy support falling short of expectations, execution delays, and slower-than-expected economic recovery[5] - For Excellence New Energy, risks involve trade barriers and raw material price fluctuations impacting profitability[16] - For Yipuli, risks include raw material price volatility and project execution delays affecting revenue growth[21]

Core Viewpoint - The company has shown significant revenue growth in 2024, but net profit has decreased, indicating challenges in profitability despite strong sales performance [1][2]. Financial Performance - In 2024, the company achieved revenue of 1.38 billion yuan, a year-on-year increase of 54.94%, while the net profit attributable to shareholders was -12 million yuan, a decrease of 108.21% [1]. - For Q1 2025, the company reported revenue of 294 million yuan, a year-on-year increase of 24.89%, with a net profit of -15 million yuan, down 143.69% [1]. Business Operations - The company’s revenue from testing and measurement equipment reached 985 million yuan and 361 million yuan respectively in 2024, with growth rates of +50.47% and +62.85% [2]. - The gross margins for these segments were 52.52% and 37.53%, reflecting increases of 0.28 percentage points and 3.68 percentage points year-on-year [2]. - As of Q1 2025, the company had contract liabilities of approximately 602 million yuan and inventory of about 2.035 billion yuan, indicating a strong order backlog [2]. Product Development - The company has expanded its product offerings to cover nine major product series, with seven types of equipment already in mass production, capturing 38.7% of the global market [3]. - New products, including advanced defect detection equipment, have been shipped to leading domestic clients for process validation and application development, representing 27.9% of the global market [3]. - The company achieved the milestone of producing its 1,000th integrated circuit quality control device in December 2024, with applications in multiple domestic production lines [3]. Strategic Initiatives - The company plans to raise up to 2.5 billion yuan through a private placement to fund high-end semiconductor quality control equipment R&D and upgrade its headquarters and R&D center [4]. - The high-end semiconductor equipment R&D project is expected to generate annual revenue of 835 million yuan upon reaching full production [4]. - The company is positioned to benefit from the ongoing trend of domestic substitution and increasing demand for advanced process measurement equipment [4]. Future Outlook - The company anticipates net profits of 155 million yuan, 390 million yuan, and 668 million yuan for the years 2025 to 2027, with corresponding price-to-earnings ratios of 161x, 64x, and 37x [4].

Core Viewpoint - The company reported its 2024 annual results and Q1 2025 results, which were generally in line with expectations, showing significant revenue growth but a decline in net profit [1] Group 1: Financial Performance - In 2024, the company's revenue reached 1.38 billion, representing a year-on-year increase of 54.9%. However, the non-recurring net profit was -124 million, compared to 32 million in 2023, and the net profit attributable to shareholders was -12 million, down from 140 million in 2023 [1] - For Q1 2025, the company reported revenue of 294 million, a year-on-year growth of 24.9%. The net profit attributable to shareholders was -15 million, compared to 34 million in the same period last year, and the non-recurring net profit was -43 million, down from 8 million year-on-year [1] Group 2: Research and Development - In Q1 2025, the company significantly increased its R&D investment, with expenses reaching 120 million, a year-on-year increase of 64%. The R&D expense ratio was 40.9%, up by 4.8 percentage points from the full year of 2024 [1] - The company’s products include nine series of equipment, covering 66% of the market space for defect detection equipment, and the increased R&D spending is expected to accelerate domestic substitution in a broad market [1] Group 3: Product Development and Market Position - The company has delivered over 300 units of its non-pattern wafer defect detection equipment, covering more than 100 customer production lines. The new generation of equipment has been validated by several leading domestic logic and memory customers [2] - In the logic chip sector, the equipment utilizes deep ultraviolet imaging scanning technology and is capable of mass supply to all major domestic customers. In the memory chip sector, the products can detect surface particle defects, effectively addressing contamination and defect monitoring during manufacturing processes [2] - The company is actively advancing the development of higher sensitivity equipment in the logic chip sector and has made significant progress in developing more advanced models. In the memory chip sector, the products can perform high-precision inspections of the three-dimensional structure of memory chips [2] Group 4: Investment Analysis - The investment analysis suggests a slight downward adjustment in profit forecasts while maintaining a "buy" rating. The company is expected to see revenues of 1.87 billion, 2.38 billion, and 2.86 billion for 2025 to 2027, with year-on-year growth rates of 35.4%, 27.1%, and 20.2% respectively [3] - The net profit attributable to shareholders is projected to be 178 million, 277 million, and 520 million for the same period, with corresponding year-on-year growth rates indicating a return to profitability and significant increases thereafter [3] - The dynamic price-to-earnings ratios are expected to be 148, 95, and 51 times for 2025 to 2027, reflecting the anticipated improvement in product coverage and process levels due to increased R&D investment [3]

Investment Rating - The investment rating for the company is "Outperform" (maintained) [1] Core Insights - The company reported its 2024 annual results and Q1 2025 results, which were generally in line with expectations. In 2024, the company's revenue reached 1.38 billion, a year-on-year increase of 54.9%. The net profit attributable to the parent company was -0.12 billion, compared to 1.40 billion in 2023. For Q1 2025, revenue was 0.294 billion, a year-on-year increase of 24.9%, with a net profit of -0.15 billion, down from 0.34 billion in the same period last year [6][8] Financial Data and Profit Forecast - The company is expected to achieve total revenue of 1.87 billion in 2025, with a year-on-year growth rate of 35.4%. The net profit attributable to the parent company is projected to be 0.178 billion, marking a return to profitability [7][10] - The gross profit margin is expected to be 49.3% in 2025, with a gradual increase to 51.3% by 2027 [7][10] R&D Investment and Product Development - In Q1 2025, the company significantly increased its R&D investment, reaching 0.12 billion, a 64% year-on-year increase, with an R&D expense ratio of 40.9% [8] - The company has delivered over 300 units of its non-pattern wafer defect detection equipment, covering more than 100 customer production lines, and has validated its new generation of equipment with major domestic clients [8] - The company is actively developing higher sensitivity equipment for logic chips and has made significant progress in the advanced packaging sector, capturing a large market share among domestic leading clients [8] Investment Analysis Opinion - The profit forecast has been slightly adjusted downward due to increased R&D investments, which may pressure short-term profitability. However, the long-term outlook remains positive, with expected revenues of 1.87 billion, 2.38 billion, and 2.86 billion for 2025, 2026, and 2027, respectively [8] - The net profit for 2025 is projected to be 0.178 billion, with significant growth expected in subsequent years, leading to a dynamic P/E ratio of 148 for 2025 [8]

25Q1收入同比稳健增长，毛利率同环比提升明显，费用短期影响利润表现。 25Q1收入2.94亿元，同比 +24.9%/环比-48.2%；毛利率58.1%，同比+3.7pcts/环比+7.5pcts；归母净利润亏损0.15亿元，同比减少 0.5亿元/环比减少0.55亿元；扣非净利润亏损0.43亿元，同比减少0.5亿元/环比减少0.4亿元。公司加速新 品研发和产品向更先进制程工艺迭代，股权激励费用、职工薪酬、研发投入等同比均有较大幅增长，而 一季度收入由于季节性影响基数较低，导致公司利润短期仍承压。 2024全年检量测设备收入同比均高增长，量测设备毛利率稳步提升。 公司整体收入和订单规模均快速 增长，2024年检测设备收入9.85亿元，同比+50.5%，销售机台176台，同比+53%，毛利率52.52%，同比 +0.28pct；量测设备收入3.61亿元，同比+62.9%，销售机台106台，同比+37.7%，毛利率37.5%，同比 +3.68pcts。 暗场设备出货量快速增长，明场设备验证进展顺利，关键尺寸设备实现对国内主流客户销售。1）无图 形晶圆缺陷检测设备： 公司订单量稳步增长，灵敏度更高的新一代产品通过多家 ...

风险高、业绩不稳定、退市风险高等特点，投资者面临较大的市场风险。投 资者应充分了解科创板市场的投资风险及本公司所披露的风险因素，审慎作 出投资决定。 Skyverse Technology Co., Ltd. （深圳市龙华区观澜街道新澜社区观光路 1301-14 号 101、102） 首次公开发行股票并在科创板上市 招股说明书 （注册稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程 序。本招股说明书不具有据以发行股票的法律效力，仅供预先披露之用。 投资者应当以正式公告的招股说明书作为投资决定的依据。 中国证监会、上海证券交易所对本次发行所作的任何决定或意见，均不表 明其对发行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证， 也不表明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判 断或保证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由 发行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自 行承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资 风险。 发行人及全体董事、监事、高级管理 ...